ScoreWhy is Hikma Pharmaceuticals Plc ?
1
Flat results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at GBP 646.15 MM
- RAW MATERIAL COST(Y) Grown by 5.22% (YoY)
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.86 times
2
With ROE of 14.54%, it has a very expensive valuation with a 1.70 Price to Book Value
- Over the past year, while the stock has generated a return of -29.13%, its profits have fallen by -11.1%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -29.13% returns in the last 1 year, the stock has also underperformed FTSE 100 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hikma Pharmaceuticals Plc for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hikma Pharmaceuticals Plc
-29.13%
-1.30
33.42%
FTSE 100
17.87%
1.52
11.77%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.85%
EBIT Growth (5y)
-0.23%
EBIT to Interest (avg)
7.98
Debt to EBITDA (avg)
1.03
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
0.80
Tax Ratio
20.49%
Dividend Payout Ratio
45.19%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.66%
ROE (avg)
16.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.70
EV to EBIT
9.70
EV to EBITDA
7.06
EV to Capital Employed
1.48
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
1.35%
ROCE (Latest)
15.24%
ROE (Latest)
14.54%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
ROCE(HY)
Highest at 16.22%
CASH AND EQV(HY)
Highest at GBP 263.19 MM
-7What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at GBP 646.15 MM
RAW MATERIAL COST(Y)
Grown by 5.22% (YoY
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.86 times
INTEREST(Q)
Highest at GBP 46.3 MM
Here's what is working for Hikma Pharmaceuticals Plc
Cash and Eqv
Highest at GBP 263.19 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Hikma Pharmaceuticals Plc
Operating Cash Flow
Lowest at GBP 646.15 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (GBP MM)
Interest
Highest at GBP 46.3 MM
in the last five periods and Increased by 50.09% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (GBP MM)
Inventory Turnover Ratio
Lowest at 1.86 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 5.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
